In reply- Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19

Mayo Clin Proc. 2020 Nov;95(11):2561-2563. doi: 10.1016/j.mayocp.2020.09.011. Epub 2020 Sep 14.

Authors

Fabian Sanchis-Gomar¹, Carl J Lavie², Carme Perez-Quilis¹, Brandon M Henry³, Giuseppe Lippi⁴

Affiliations

¹ University of Valencia, INCLIVA Biomedical Research Institute, Valencia, Spain.
² John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana.
³ The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
⁴ University of Verona, Verona, Italy.

No abstract available

Publication types

Letter
Comment

MeSH terms

Betacoronavirus*
COVID-19*
Coronavirus Infections* / epidemiology
Humans
Pandemics
Renin-Angiotensin System